Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1243-1249

  Bowersox, S Scott ^a   Gadbois, Theresa ^a   Singh, Tejinder ^a   Pettus, Mark ^a   Wang, Yong Xiang ^a   Luther, Robert R ^a  

^a Neurex Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; OMEGA CONOTOXIN MVIIA;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BOLUS INJECTION; CALCIUM TRANSPORT; CHRONIC PAIN; DOSE RESPONSE; INTRASPINAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NEUROPATHY; NONHUMAN; PAIN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SECOND MESSENGER; SOMATOSENSORY SYSTEM; SUBARACHNOID SPACE;

ANALGESICS; ANIMALS; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; FORMALDEHYDE; ION CHANNEL GATING; MALE; NEURONS; OMEGA-CONOTOXINS; PAIN; PEPTIDES; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0030434482     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. BENEDEK, G. AND SZIKSZAY, M.: Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists. Pharmacol. Res. Commun. 16: 1009-1018, 1984.
2. BENNETT, G. J. AND XIE, Y.-K.: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107, 1988.
3. BOWERSOX, S. S., VALENTINO, K. L. AND LUTHER, R. R.: Neuronal voltage-sensitive calcium channels. Drug News Perspect. 7: 261-268, 1994.
4. BROSE, W. G., CHERUKURI, S., LONGTON, W. C., GAETA, R. R., PRESLEY, R. AND LUTHER, R. R.: Safety and efficacy of intrathecal SNX-111, a novel analgesic, in the management of intractable neuropathic and nociceptive pain in humans: preliminary results. Presented at the 14th Annual Meeting, American Pain Society, November 9-12, Los Angeles, California, 1995.
5. CARTA, F., BIANCHI, M., ARGENTRON, S., CERVI, D., MAROLLA, G., TAMBURINI, M., BREDA, M., FANTONI, A. AND PANERAI, A. E.: Effect of nifedipine on morphine-induced analgesia. Anesth. Analg. 70: 493-498, 1990.
6. CERVERO, F. AND IGGO, A.: The substantia gelatinosa of the spinal cord. Brain 103: 717-772, 1980.
7. CHAPLAN, S. R., BACH, F. W., POGREL, J. W., CHUNG, J. M. AND YAKSH, T. L.: Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53: 55-63, 1994a.
8. CHAPLAN, S. R., POGREL, J. W. AND YAKSH, T. L.: Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J. Pharmacol. Exp. Ther. 269: 1117-1123, 1994b.
9. CODERRE, T. J. AND MELZACK, R.: The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. J. Neurosci. 12: 3671-3675, 1992.
10. CONTRERAS, E., TAMAYO, L. AND AMIGO, M.: Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance. Eur. J. Pharmacol. 148: 463-466, 1988.
11. DEL POZO, E., CARO, G. AND BAEYENS, J. M.: Analgesic effects of several calcium channel blockers in mice. Eur. J. Pharmacol. 137: 155-160, 1987.
12. DIXON W. J.: Efficient analysis of experimental observations. Annu. Rev. Pharmacol. Toxicol. 20: 441-462, 1980.
13. DUBUISSON, D. AND DENNIS, S. G.: The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain-stem stimulation in rats and cats. Pain 4: 161-174, 1977.
14. GAUR, S., NEWCOMB, R., RIVNAY, B., BELL, J. R., RAMACHANDRAN, J. AND MILJANICH, G. P.: Calcium channel antagonist peptides define several components of transmitter release in the hippocampus. Neuropharmacology 33: 1211-1219, 1994.
15. GOHIL, K., BELL, J. R., RAMACHANDRAN, J. AND MILJANICH, G. P.: Neuroanatomical distribution of receptors for a novel voltage-sensitive calcium channel antagonist, SNX-230 (ω-conopeptide MVIIC). Brain Res. 653: 258-266, 1994.
16. GOHIL, K., BOWERSOX, S., SINGH, T., RAMACHANDRAN, J. AND MILJANICH, G.: SNX-111, a selective inhibitor of N-type voltage-sensitive calcium channels is antinociceptive in the rat hindpaw formalin test. Soc. Neurosci. Abstr. 19: 235, 1993.
17. HILLYARD, D. R., MONJE, V. D., MINTZ, I. M., BEAN, B. P., NADASDI, L., RAMACHANDRAN, J., MILJANICH, G., AZIMI-ZOONOOZ, A., MCINTOSH, J. M., CRUZ, L., IMPERIAL, J. S. AND OLIVERA, B. M.: A new Conus peptide ligand for mammalian presynaptic calcium channels. Neuron 9: 69-77, 1992.
18. HOFFMEISTER, F. AND TETTENBORN, D.: Calcium agonist and antagonists of the dihydropridine type: Antinociceptive effects, interference with opiate-mureceptor agonists and neuropharmacological actions in rodents. Psychopharmacology (Berl.) 90: 299-307, 1986.
19. 2+ channel diversity. Annu. Rev. Neurosci. 17: 399-418, 1994.
20. KAVALIERS, M.: Stimulatory influences of calcium channel antagonists on stress-induced opioid analgesia and locomotor activity. Brain Res. 408: 403-407, 1987.
21. 125I]ω-conotoxin in the rat brain. Eur. J. Pharmacol. 146: 181-183, 1988.
22. KIM, S. H. AND CHUNG, J. M.: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: 355-363, 1992.
23. MALMBERG, A. B. AND YAKSH, T. L.: Antinociceptive actions of spinal nonsteroidal antiinflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 263: 136-146, 1992.
24. MALMBERG, A. B. AND YAKSH, T. L.: Voltage-sensitive calcium channels in spinal nociceptive processing: Blockade of N- and P-type channels inhibits formalin-induced nociception. J. Neurosci. 14: 4882-4890, 1994.
25. MALMBERG A. B. AND YAKSH, T. L.: Effect of continuous intrathecal infusion of ω-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60: 83-90, 1995.
26. MCCLESKEY, E. W.: Calcium channels: Cellular roles and molecular mechanisms. Curr. Opin. Neurobiol. 4: 304-312, 1994.
27. MECKE, E., KAUPPILA, T., CARLSON, S. AND PERTOVAARA, A.: Differential effects of verapamil, a calcium channel antagonist, on morphine and cocaine-induced analgesia and locomotor behavior in rats. Neurosci. Res. Commun. 9: 137-142, 1991.
28. MILJANICH, G. P. AND RAMACHANDRAN, J.: Antagonists of neuronal calcium channels: structure, function, and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 38: 707-735, 1995.
29. 2+ channel blockers. Eur. J. Pharmacol. 217: 137-141, 1992.
30. NADASDI, L., YAMASHIRO, D., CHUNG, D., TARCZY-HORNOCH, K., ADRIAENSSENS, P. AND RAMACHANDRAN, J.: Structure-activity analysis of a Conus peptide blocker of N-type calcium channels. Biochemistry 34: 8076-8081, 1995.
31. OLIVERA, B. M., CRUZ, L. J., D. E. SANTOS, V., L. E. CHEMINANT, G. W. AND GRIFFIN, D., ET AL.: Neuronal calcium channel subtypes using ω-conotoxin from Conus magus venom. Biochemistry 26: 2086-2090, 1987.
32. OLIVERA, B. M., MILJANICH, G. P., RAMACHANDRAN, J. AND ADAMS, M. E.: Calcium channel diversity and neurotransmitter release: The ω-conotoxins and ω-agatoxins. Annu. Rev. Biochem. 63: 823-867, 1994.
33. OMOTE, K., IWAKSAKI, H., KAWAMATA, M., SATOH, O. AND NAMIKI, A.: Effects of verapamil on spinal anesthesia with local anesthetics. Anesth. Analg. 80: 444-448, 1995.
34. OMOTE, K., SONODA, H., KAWAMATA, M., IWASAKI, H. AND NAMIKI, A.: Potentiation of antinociceptive effects of morphine by calcium channel blockers at the level of the spinal cord. Anesthesiology 79: 746-752, 1993.
35. SANTICIOLI, P., DEL BIANCO, E., TRAMONTANA, M., GEPPETTI, P. AND MAGGI, C. A.: Release of calcitonin gene-related peptide-like immunoreactivity induced by electrical field stimulation from rat spinal afferents is mediated by conotoxin-sensitive calcium channels. Neurosci. Lett. 136: 161-164, 1992.
36. SANTILLAN, R., MAESTRE, J. M., HURLE, H. A. AND FLOREZ, J.: Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: A preliminary report. Pain 58: 129-132, 1994.
37. STEVENS, C. W. AND YAKSH, T. L.: Magnitude of opioid dependence after continuous intrathecal infusion of μ and ∂-selective opioids in the rat. Eur. J. Pharmacol. 166: 467-472, 1989a.
38. STEVENS, C. W. AND YAKSH, T. L.: Potency of infused spinal antinociceptive agents is inversely related to the magnitude of tolerance after continuous infusion. J. Pharmacol. Exp. Ther. 250: 1-8, 1989b.
39. TAKEMURA, M., KIYAMA, H., FUKUI, H., TOHYAMA, M. AND WADA, H.: Autoradiographic visualization in rat brain of receptors for ω-conotoxin GVIA, a newly discovered calcium antagonist. Brain Res. 45: 386-389, 1988.
40. XIAO, W-H. AND BENNETT, G. J.: Calcium channel blockade with synthetic omega-conopeptides applied to the site of nerve injury suppresses neuropathic pains in rate. J. Pharmacol. Exp. Ther. 274: 666-672, 1995.
41. YAKSH, T. L.: Spinal opiate analgesia: Characteristics and principles of action. Pain 11: 293-346, 1981.
42. YAKSH, T. L. AND RUDY, T. A.: Chronic catheterization of the spinal subarachnoid space. J. Physiol. Behav. 17: 1031-1036, 1976.
43. YAMASHIRO, D. AND LI, C. H.: New segment synthesis of alpha-inhibin-92 by the acyl disulfide method. Int. J. Peptide Protein Res. 31: 322-334, 1988.